Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2000
11/21/2000US6150304 2-aryl-cyclopentane-1,3-dione derivatives
11/21/2000US6150042 Material for organoelectro-luminescence device and use thereof
11/21/2000CA1341145C High temperature process for selective production of 3-methylpyridine
11/21/2000CA1341144C Process for selective production of 3-methylpyridine
11/16/2000WO2000068280A1 Polymerization of ethylene
11/16/2000WO2000068204A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
11/16/2000WO2000068198A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000WO2000068191A1 Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
11/16/2000WO2000068190A2 1-alkoxy and 1-acyloxy substituted cyclohex-1-ene compounds and sulfur and 1-alkoxycarbonyl analogs having retinoid-like biological activity
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000068178A1 Novel compounds
11/16/2000WO2000067801A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/16/2000WO2000067754A1 Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000048996A3 β-ALANINE DERIVATIVES
11/16/2000WO2000041469A3 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000015634A3 Hiv protease inhibitors
11/16/2000CA2373076A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
11/16/2000CA2369323A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000CA2368831A1 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/16/2000CA2336673A1 Novel compounds
11/15/2000EP1052253A1 Process for the preparation of 2,3-pyridinedicarboxylic acids
11/15/2000EP1052252A1 Diaminobenzene derivatives and dyeing preparations containing them
11/15/2000EP1052238A1 Novel tricyclic compound
11/15/2000EP1051399A1 Phenylalanine derivatives useful as pharmaceutical agents
11/15/2000EP1051394A1 Potassium channel inhibitors
11/15/2000EP1051383A1 Hydroxylation activated prodrugs
11/15/2000EP1051169A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
11/15/2000EP0842227B1 Azothiophenes
11/15/2000CN1273579A Anthranilic acid analogs
11/15/2000CN1273236A Fungicide and insecticide benzyloxycyclopropyl substituted aromatic compund fungicide
11/15/2000CN1058495C Polycyclic systems compound and derivatives thereof as neurotransmitter release enhancers useful in the treatment of cognitive disordes and medicine containing them and its use
11/14/2000US6147255 Topical and systemic treatment of dermatological complaints associated with keratinization disorder which has effect on differentiation and on proliferation
11/14/2000US6147253 N-protected/N-substituted-beta-amino-hydroxy sulfonates
11/14/2000US6147218 2-phenylpyridine derivative and production method thereof
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147116 Polyaromatic antiviral compositions
11/14/2000US6147082 Chalcones having antiproliferative activity
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147074 Arylsulfonylamino hydroxamic acid derivatives
11/14/2000CA1341138C Fluorine-containing chiral smectic liquid crystals
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066557A1 New compounds
11/09/2000WO2000066550A1 New compounds
11/09/2000WO2000066546A2 Monofluoroalkyl derivatives
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066524A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066123A1 Synergistic combination comprising roflumilast and a pde-3 inhibitor
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000039095A3 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000DE19921424A1 Substituierte Benzoylketone Substituted benzoyl ketones
11/09/2000CA2372672A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000CA2372490A1 Monofluoroalkyl derivatives
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000CA2371215A1 New compounds
11/08/2000EP1050531A1 Pyridine and piperidine derivatives for treating neurodegenerative diseases
11/08/2000EP1050528A1 Fungicidal and insecticidal benzyloxy cyclopropyl substituted aromatic compounds
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049663A1 Organic nitrile derivatives and their use as pesticides
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000EP1049537A2 Catalytic compositions and methods for asymmetric allylic alkylation
11/08/2000EP1049468A1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
11/08/2000EP0862550B1 Carboxylic acid derivatives, their preparation and their use
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/07/2000US6143899 Reacting 2-fluoro-6-trifluoromethylpyridine or a mixture of 2-fluoro-6-trifluoromethylpyridine and 2-chloro-6-trifluoromethylpyridine with an alkali metal hydroxide, heating and acidifying the product formed
11/07/2000US6143894 Preparation of [1S-[1A,2B,3B,4A(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl propyl]amino] -3H-imidazo[4,5-B]pyridin-3-yl]-N-ethyl-2,3-dihydroxycyclopentanecarboxa mide
11/07/2000US6143892 Process for making 5-substituted pyrazoles
11/07/2000US6143789 Enantiomorphs
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143751 Pyridine derivatives and pharmaceutical compositions containing them
11/07/2000US6143747 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/07/2000US6143744 Sulfamide-metalloprotease inhibitors
11/07/2000US6143198 Liquid crystalline compounds having exo-methylene site and liquid crystal compositions comprising the same
11/07/2000CA2118102C New derivatives of 1,2,3,4-tetrahydronaphthalene, preparation process thereof and pharmaceutical compositions containing the same
11/07/2000CA1341136C Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
11/02/2000WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064885A1 Heteroaryl diazacycloalkanes, their preparation and use
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064875A1 Method for pulvirizing to fine powder
11/02/2000WO2000064874A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000WO2000064860A1 Polyaldimines of oligomeric aminobenzoic acid derivatives, and their use for preparation of moisture-curable, storage-stable, one-part polyreas
11/02/2000WO2000064859A1 Amide derivatives
11/02/2000WO2000064478A1 Preventives/remedies for liver diseases
11/02/2000WO2000064477A1 Preventives/remedies for angiostenosis
11/02/2000WO2000064430A1 Apoptosis inhibitors
11/02/2000WO2000047560A3 Process for the preparation of asymmetrical 1,4-dihydro-pyridine-dicarboxylic acid esters
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000EP1048654A2 Process for the preparation of chloropyridine sulfonyl chloride
11/02/2000EP1048641A1 Apoptosis inducer
11/02/2000EP1047979A2 Compound, composition and use
11/02/2000EP1047692A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
11/02/2000EP1047679A1 Herbicidal n-alkenyl heteroarylyloxyacetamides
11/02/2000EP1047674A1 Process for production of donepezil derivatives